Search the Archive

In Depth (Targeting Cancer) #729762

NBC Evening News for Sunday, Jun 01, 2003
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio: John Seigenthaler) Report introduced.

(Chicago: Robert Bazell) Word that two new drugs may offer help in the targeting colon cancer featured; details given about the two anti-angiogenesis drugs Genentech's Avastin†† & ImClone's Erbitux††. [Cancer volunteer Jane ST. GEORGE‡- says she was told about her cancer.] [Duke University Medical Center Dr. Herbert HURWITZ†- says we were surprised the drug work on colon cancer with modest side effects.] [Memorial Sloan-Kettering Cancer center Dr. Leonard SALTZ†- says we are making inroads.] [Cancer patient Joseph SPATAFINA‡- comments.]

Seigenthaler, John;
Bazell, Robert

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.